Previous 10 | Next 10 |
Recent news releases related news releases and press releases from 04/24/24 10:06:58 on US and Canada Markets.
Mifflintown, PA, April 24, 2024 (GLOBE NEWSWIRE) -- Juniata Valley Financial Corp. (OTCQX:JUVF) (“Juniata”), announced net income for the three months ended March 31, 2024 of $1.4 million, a decrease of 21.8%, compared to net income of $1.7 million for the three months ended March 3...
Oral presentation of MDNA11’s Phase 1/2 ABILITY-1 Study will feature new and updated clinical data Updated bizaxofusp survival results from the Phase 2b recurrent glioblastoma trial versus propensity matched external control arm will also be presented as a poster TORONTO an...
Oral presentation of MDNA11’s Phase 1/2 ABILITY-1 Study will feature new and updated clinical data Updated bizaxofusp survival results from the Phase 2b recurrent glioblastoma trial versus propensity matched external control arm will also be presented as a poster TORONTO an...
Bicycle Therapeutics plc (NASDAQ: BCYC), a biopharmaceutical company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (Bicycle ® ) technology, today announced the acceptance of two abstracts for poster presentation at the 2024 Amer...
Duke Energy's annual Impact Report shares progress toward a cleaner tomorrow that includes affordability and reliability PR Newswire Carbon emissions from electric generation are down 48% from 2005 levels Since 2022, helped customers access nearly $377 million in finan...
IDEAYA Biosciences Announces ASCO 2024 Oral Presentation for Darovasertib in Neoadjuvant Uveal Melanoma Phase 2 Investigator Sponsored Study PR Newswire Oral presentation at ASCO 2024 scheduled for Monday, June 3, 2024 , at 9:51 AM CDT The abstract summary wil...
Nuvation Bio Inc. (NYSE: NUVB), a late-stage, global biopharmaceutical company tackling some of the greatest unmet needs in oncology by developing differentiated and novel therapeutic candidates, today announced that updated data from the Phase 2 TRUST-I clinical study (NCT04395677) evaluating ta...
BOSTON, April 24, 2024 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively modulate disease-specific T cells, announced today that it will present an oral abstract and poster at...
New research has discovered that individuals who use CBD for crack-use disorder may have fewer adverse health events as well as better health outcomes . This is in comparison to patients who were on conventional treatments. For their study, the researchers conducted a double-blind, randomized...
Last week, the price of gold held steady with increasing geopolitical risks continuing to prop its prices up. This is despite the fact that the Fed also signaled a potential delay in a reduction in rates of interest. U.S. gold futures dropped by 0.2% to reach $2,402.50 an ounce in New York wh...
News, Short Squeeze, Breakout and More Instantly...
Trending Stock
9.78%Change Percent:
Hurco Companies Inc. Company Name:
HURC Stock Symbol:
NASDAQ Market:
hurco.com Website: